PharmaCyte Biotech Inc (PMCB)
NASDAQ
Quarter End | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 | Jan 2024 | Apr 2024 | Jul 2024 | Oct 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -1.55M | -902k | -2.08M | -1.41M | -1.87M | -3.17M | -1.27M | -1.11M |
Pre Tax Income | -764k | -126k | -3.18M | 2.79M | -620k | 1.35M | 23.42M | -1.47M |
Net Income | -764k | -126k | -3.5M | -5.53M | -5.66M | -2.54M | 20.59M | -2.96M |
Preferred Dividends | 0 | 0 | -320k | -8.32M | -5.04M | 11.17M | -685k | -445k |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -1.41M | -848k | -2.08M | -1.41M | -1.73M | -3.6M | -1.02M | -672k |
EBITDA | -1.55M | -902k | -2.08M | -1.41M | -1.87M | -1.17M | -1.27M | -1.11M |
Year End April 29 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -4.44M | -6.98M | -4.1M | -3.83M | -3.62M | -4.39M | -6.46M | -8.52M |
Pre Tax Income | -4.44M | -6.83M | -4.07M | -3.83M | -3.55M | -4.24M | -4.32M | 334k |
Net Income | -4.44M | -6.83M | -4.07M | -3.83M | -3.55M | -4.24M | -4.32M | -17.24M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.52M |
Basic Earnings Per Share (EPS) | -0.005 | -0.007 | -0.003 | -0.002 | -0.351 | -0.145 | -0.162 | -1.015 |
EBIT | -4.44M | -6.83M | -4.07M | -3.83M | -3.55M | -4.4M | -6.25M | -8.81M |
EBITDA | -4.44M | -6.98M | -4.1M | -3.83M | -3.62M | -4.39M | -6.46M | -6.52M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.